Immunomagnetic Reduction Detects Plasma Aβ1–42 Levels as a Potential Dominant Indicator Predicting Cognitive Decline

Written by Yiran Gan
Immunomagnetic Reduction Detects Plasma Aβ1–42 Levels as a Potential Dominant Indicator Predicting Cognitive Decline - Yang et al. 2020

Immunomagnetic Reduction Detects Plasma Aβ1–42 Levels as a Potential Dominant Indicator Predicting Cognitive Decline

Publication Date: 2020.11.02

Authors: SY Yang, HC Liu and WP Chen

Journal: Neurol Therapy (2020)

© 2020 Yang, Liu and Chen

Neurology and Therapy

Yiran Gan
Previous

Development of Assaying Plasma TDP-43 Utilizing Immunomagnetic Reduction
Next

Classifications of Neurodegenerative Disorders Using a Multiplex Blood Biomarkers-Based Machine Learning Model